Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | DRD1 | P21728 | 5/20 | 0.42 |
| ▸ | DRD5 | P21918 | 5/20 | 0.42 |
| ▸ | DRD2 | P14416 | 4/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30376019 | 1.00 | MEN1 (0.48) | MEN1KMT2ACYP3A4TSHRHSD17B10 | |
| SCHEMBL14800367 | 0.95 | MEN1 (0.44) | MEN1KMT2ACYP3A4TSHRHSD17B10 | |
| SCHEMBL1808685 | 0.94 | MEN1 (0.52) | MEN1KMT2ACYP3A4TSHRHSD17B10 | |
| SCHEMBL7914941 | 0.94 | MEN1 (0.52) | MEN1KMT2ACYP3A4TSHRHSD17B10 | |
| SCHEMBL31274423 | 0.94 | MEN1 (0.52) | MEN1KMT2ACYP3A4TSHRHSD17B10 | |
| SCHEMBL29604701 | 0.94 | MEN1 (0.52) | MEN1KMT2ACYP3A4TSHRHSD17B10 | |
| Anthracene SCHEMBL2876495 | 0.91 | CYP3A4 (0.50) | MEN1KMT2ACYP3A4TSHRHSD17B10 | |
| SCHEMBL19810032 | 0.88 | MEN1 (0.48) | MEN1KMT2ACYP3A4TSHRHSD17B10 | |
| SCHEMBL19810040 | 0.88 | CYP1A2 (0.46) | MEN1KMT2ACYP3A4TSHRHSD17B10 | |
| SCHEMBL4621881 | 0.85 | MEN1 (0.41) | MEN1KMT2ACYP3A4TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110662737-B | Method for producing methyl methacrylate or methacrylic acid | 三菱化学英国有限公司 | 2023-04-28 | — | — | CN | claimed |
| US-11174215-B2 | Method of producing methyl methacrylate or methacrylic acid | Mitsubishi Chemical UK Limited (GB) | 2021-11-16 | — | — | US | claimed |
| US-10693074-B2 | 5,12-dihydrotetracene derivative and organic electroluminescence device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2020-06-23 | — | — | US | claimed |
| EP-3601214-A1 | METHOD OF PRODUCING METHYL METHACRYLATE OR METHACRYLIC ACID | Lucite International UK Limited (GB) | 2020-02-05 | — | — | EP | claimed |
| US-20200031754-A1 | METHOD OF PRODUCING METHYL METHACRYLATE OR METHACRYLIC ACID | Mitsubishi Chemical UK Limited (GB) | 2020-01-30 | — | — | US | claimed |
| CN-110662737-A | Method for producing methyl methacrylate or methacrylic acid | 卢塞特英国国际有限公司 | 2020-01-07 | — | — | CN | claimed |
| US-20190229270-A1 | 5,12-DIHYDROTETRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2019-07-25 | — | — | US | claimed |
| WO-2018172783-A1 | METHOD OF PRODUCING METHYL METHACRYLATE OR METHACRYLIC ACID | LUCITE INTERNATIONAL UK LIMITED (GB) | 2018-09-27 | — | — | WO | claimed |
| CN-110662737-B | Method for producing methyl methacrylate or methacrylic acid | 三菱化学英国有限公司 | 2023-04-28 | — | — | CN | disclosed |
| US-11174215-B2 | Method of producing methyl methacrylate or methacrylic acid | Mitsubishi Chemical UK Limited (GB) | 2021-11-16 | — | — | US | disclosed |
| US-11005047-B2 | Heteroaromatic compound and organic electroluminescence device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2021-05-11 | — | — | US | disclosed |
| US-10844043-B2 | Heteroaromatic compound and organic electroluminescence device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2020-11-24 | — | — | US | disclosed |
| US-10693074-B2 | 5,12-dihydrotetracene derivative and organic electroluminescence device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2020-06-23 | — | — | US | disclosed |
| US-10693074-B2 | 5,12-dihydrotetracene derivative and organic electroluminescence device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2020-06-23 | — | — | US | disclosed |
| CN-102869660-A | Aminothiazolones as estrogen related receptor-alpha modulators | JANSSEN PHARMACEUTICA NV | 2013-01-09 | — | — | CN | disclosed |
| US-5808154-A | Process for the production of an aromatic hydrazo compound | TOYO INK MANUFACTURING CO., LTD. (JP) | 1998-09-15 | — | — | US | disclosed |
| EP-0391606-B1 | Process for the production of an aromatic hydrazo compound | TOYO INK MFG CO (JP) | 1995-07-05 | — | — | EP | disclosed |
| US-4981962-A | CHARGE TRANSFER COMPLEXES | CIBA-GEIGY CORPORATION (US) | 1991-01-01 | — | — | US | disclosed |
| EP-0391606-A1 | Process for the production of an aromatic hydrazo compound | TOYO INK MANUFACTURING CO., LTD. (JP) | 1990-10-10 | — | — | EP | disclosed |
| US-4617151-A | 2- or 2,3-substituted 5,6,11,12-tetrathiotetracene and 5,6,11,12-tetraselenotetracene | CIBA-GEIGY CORPORATION (US) | 1986-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10844043-B2 | Heteroaromatic compound and organic electroluminescence device using the same | VDAC1, TRPC6, TRPC5 | MEN1 1722/4885KMT2A 1998/4885CYP3A4 30/4885 |
| US-11174215-B2 | Method of producing methyl methacrylate or methacrylic acid | MMAB, MEP1A, MTR | MEN1 683/4885KMT2A 461/4885CYP3A4 1303/4885 |
| US-11005047-B2 | Heteroaromatic compound and organic electroluminescence device using the same | ARNT, TRPC6, DDT | MEN1 2365/4885KMT2A 1721/4885CYP3A4 23/4885 |
| US-10693074-B2 | 5,12-dihydrotetracene derivative and organic electroluminescence device using the same | MT-ND5, DLD, TRPC5 | MEN1 4202/4885KMT2A 1792/4885CYP3A4 551/4885 |
| US-20200031754-A1 | METHOD OF PRODUCING METHYL METHACRYLATE OR METHACRYLIC ACID | MMAB, MEP1A, MTR | MEN1 683/4885KMT2A 461/4885CYP3A4 1303/4885 |
| US-20190229270-A1 | 5,12-DIHYDROTETRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | MT-ND5, DLD, TRPC5 | MEN1 4202/4885KMT2A 1792/4885CYP3A4 551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.